| Literature DB >> 26964483 |
Emma Portnoy1, Boris Polyak2, Dorrit Inbar3, Gilad Kenan4, Ahmad Rai5, Suzanne L Wehrli6, Timothy P L Roberts7, Ameer Bishara8, Aniv Mann9, Miriam Shmuel10, Katya Rozovsky11, Gal Itzhak12, Tamir Ben-Hur13, Shlomo Magdassi14, Dana Ekstein15, Sara Eyal16.
Abstract
Correct localization of epileptic foci can improve surgical outcome in patients with drug-resistant seizures. Our aim was to demonstrate that systemically injected nanoparticles identify activated immune cells, which have been reported to accumulate in epileptogenic brain tissue. Fluorescent and magnetite-labeled nanoparticles were injected intravenously to rats with lithium-pilocarpine-induced chronic epilepsy. Cerebral uptake was studied ex vivo by confocal microscopy and MRI. Cellular uptake and biological effects were characterized in vitro in murine monocytes and microglia cell lines. Microscopy confirmed that the nanoparticles selectively accumulate within myeloid cells in the hippocampus, in association with inflammation. The nanoparticle signal was also detectable by MRI. The in vitro studies demonstrate rapid nanoparticle uptake and good cellular tolerability. We show that nanoparticles can target myeloid cells in epileptogenic brain tissue. This system can contribute to pre-surgical and intra-surgical localization of epileptic foci, and assist in detecting immune system involvement in epilepsy.Entities:
Keywords: Epilepsy; Imaging; Inflammation; Magnetic Resonance Imaging; Magnetic nanoparticles
Mesh:
Substances:
Year: 2016 PMID: 26964483 DOI: 10.1016/j.nano.2016.01.018
Source DB: PubMed Journal: Nanomedicine ISSN: 1549-9634 Impact factor: 5.307